UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000027656
Receipt No. R000031685
Scientific Title thrombocytosis as a prognostic marker for head and neck cancer: a meta-analysis
Date of disclosure of the study information 2017/06/10
Last modified on 2018/06/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title thrombocytosis as a prognostic marker for head and neck cancer: a meta-analysis
Acronym thrombocytosis and head and neck cancer
Scientific Title thrombocytosis as a prognostic marker for head and neck cancer: a meta-analysis
Scientific Title:Acronym thrombocytosis and head and neck cancer
Region
Japan

Condition
Condition head and neck squamous cell carcinoma
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 to quantify the prognostic impact of platelet count and platelet-lymphocyte ratio in head and neck squamous cell carcinoma
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Others
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes overall survival
Key secondary outcomes disease-specific survival

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) studies reporting the prognostic impact of pretreatment PC or PLR in peripheral blood in head and neck cancer, (2) studies where the hazard ratio (HR) and 95% confidence interval (CI) or p-value for overall survival (OS) and disease-specific survival (DSS) were available, (3) the histological type of the tumors was considered to be predominantly squamous cell carcinoma (SCC).
Key exclusion criteria (1) nonhuman studies and those in languages other than English, (2) studies focusing on thyroid cancer or nasopharyngeal cancer, (3) studies focusing on salivary gland cancer or nasal and paranasal cancer where SCC and non-SCC were analyzed together.
Target sample size 0

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yukinori Takenaka
Organization Osaka General Medical Center
Division name otorhinolaryngology and head and neck surgery
Zip code
Address 3-1-56 Bandai Higashi, Sumiyoshi, Osaka
TEL 0666921201
Email ysktakenaka@gmail.com

Public contact
Name of contact person
1st name
Middle name
Last name Yukinori Takenaka
Organization Osaka General Medical Center
Division name otorhinolaryngology and head and neck surgery
Zip code
Address 3-1-56 Bandai Higashi, Sumiyoshi, Osaka
TEL 0666921201
Homepage URL
Email ysktakenaka@gmail.com

Sponsor
Institute Osaka General Medical Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 05 Month 17 Day
Date of IRB
Anticipated trial start date
2017 Year 05 Month 17 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information a Meta-analysis of published studies regarding the association of PC and PLR with HNSCC in electronic databases (PubMed and Scopus)

Management information
Registered date
2017 Year 06 Month 06 Day
Last modified on
2018 Year 06 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031685

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.